| Dr Elias I Sharba, MD | |
|
18181 Oakwood Blvd, Suite 208, Dearborn, MI 48124-5032 | |
| (313) 271-5565 | |
| (313) 271-1053 |
| Full Name | Dr Elias I Sharba |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 34 Years |
| Location | 18181 Oakwood Blvd, Dearborn, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558331447 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital - Dearborn | Dearborn, MI | Hospital |
| Beaumont Hospital - Taylor | Taylor, MI | Hospital |
| Beaumont Hospital - Trenton | Trenton, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Critical Care Medicine Associates Pc | 4789607557 | 10 |
| Ccma-bt Pllc | 5698069086 | 10 |
| Pulmonary Specialists Of Michigan, Pc | 6204003999 | 7 |
News Archive
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.
Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.
An international team of researchers has found that many psychiatric disorders share a common and specific set of gene variants.
Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. with a six-month target price of $1.22 per share.
› Verified 3 days ago
| Entity Name | Critical Care Medicine Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235219403 PECOS PAC ID: 4789607557 Enrollment ID: O20060106000541 |
News Archive
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.
Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.
An international team of researchers has found that many psychiatric disorders share a common and specific set of gene variants.
Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. with a six-month target price of $1.22 per share.
› Verified 3 days ago
| Entity Name | Pulmonary Specialists Of Michigan, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265712012 PECOS PAC ID: 6204003999 Enrollment ID: O20120120000382 |
News Archive
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.
Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.
An international team of researchers has found that many psychiatric disorders share a common and specific set of gene variants.
Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. with a six-month target price of $1.22 per share.
› Verified 3 days ago
| Entity Name | Ccma-bt Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730530973 PECOS PAC ID: 5698069086 Enrollment ID: O20160808002115 |
News Archive
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.
Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.
An international team of researchers has found that many psychiatric disorders share a common and specific set of gene variants.
Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. with a six-month target price of $1.22 per share.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elias I Sharba, MD 18181 Oakwood Blvd, Suite 208, Dearborn, MI 48124-5032 Ph: (313) 271-5565 | Dr Elias I Sharba, MD 18181 Oakwood Blvd, Suite 208, Dearborn, MI 48124-5032 Ph: (313) 271-5565 |
News Archive
A Michigan State University researcher is studying whether the most popular class of cholesterol-lowering drugs may cause muscle problems in users.
Among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis, according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013.
An international team of researchers has found that many psychiatric disorders share a common and specific set of gene variants.
Zacks Equity Research initiated research coverage on CardioGenics Holdings Inc. with a six-month target price of $1.22 per share.
› Verified 3 days ago
Albagir Mohamed Alarabi, M.D Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Rama V Thyagarajan, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd Ste 101, Medical Office Building, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 | |
Adeeb M Atassi, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 18181 Oakwood Blvd, Suite Number 208, Dearborn, MI 48124 Phone: 313-563-3332 | |
Mihaela A. Lupu, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 18181 Oakwood Blvd, Ste 208, Dearborn, MI 48124 Phone: 313-271-5670 Fax: 313-271-1053 | |
Violet Asfour, Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 18100 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-436-2578 | |
Raed Haddad, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9720 Dix, Ste B, Dearborn, MI 48120 Phone: 313-843-1973 Fax: 313-843-1961 | |
Dr. Denise Kirsch, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 18101 Oakwood Blvd Ste 101, Dearborn, MI 48124 Phone: 313-436-2426 Fax: 313-436-2440 |